Remote ischemic preconditioning (RIPC) is an innovative treatment strategy that alleviates ischemia-reperfusion injury, whereby short episodes of regional ischemia and reperfusion delivered to remote organs including hind limb, kidney and intestine, and so on provide protection to the heart. The RIPC is known to reduce infarct size, serum levels of cardiac enzymes, and myocardial dysfunction in various animal species as well as in patients. There have been a large number of studies suggesting that the ATP-sensitive potassium channels (K ATP channel) play a significant role as a mediator or end effector in RIPC. The present review discusses the role of K ATP channels and possible mechanisms in RIPC-induced cardioprotection.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: